Détail d'une personne de l'annuaire - fr | Cancéropôle Est, la recherche innovante dans la lutte contre le cancer

Prognostic role of HPV integration status and molecular profile in advanced anal carcinoma: An ancillary study to the epitopes-HPV02 trial.

Debernardi A, Meurisse A, Prétet JL, Guenat D, Monnien F, Spehner L, Vienot A, Roncarati P, André T, Abramowitz L, Molimard C, Mougin C, Herfs M, Kim S, Borg C

Front Oncol. 2022 10 14;12:941676

Longitudinal follow-up of HPV16 sequence after cervical infection: low intra-host variation and no correlation with clinical evolution.

Debernardi A, Valot B, Almarcha J, Guenat D, Hocquet D, Algros MP, Riethmuller D, Ramanah R, Mougin C, Prétet JL, Lepiller Q

J Med Virol. 2022 07 7;:

Repurposing the Hybrid Capture 2 (HC2) screening test for whole-genome sequencing of human papillomaviruses.

Debernardi A, Jarassier W, Soret C, Mougin C, Alizon S, Bravo IG, Guenat D, Prétet JL, Lepiller Q

Arch Virol. 2021 Oct 7;:

Human papillomavirus DNA and p16 expression in head and neck squamous cell carcinoma in young French patients.

Molimard C, L'Huillier V, Overs A, Soret C, Algros MP, Mougin C, Guenat D, Mauvais O, Prétet JL

J Int Med Res. 2021 Jul;49(7):3000605211022534

Humans with inherited T cell CD28 deficiency are susceptible to skin papillomaviruses but are otherwise healthy.

Béziat V, Rapaport F, Hu J, Titeux M, Bonnet des Claustres M, Bourgey M, Griffin H, Bandet É, Ma CS, Sherkat R, Rokni-Zadeh H, Louis DM, Changi-Ashtiani M, Delmonte OM, Fukushima T, Habib T, Guennoun A, Khan T, Bender N, Rahman M, About F, Yang R, Rao G, Rouzaud C, Li J, Shearer D, Balogh K, Al Ali F, Ata M, Dabiri S, Momenilandi M, Nammour J, Alyanakian MA, Leruez-Ville M, Guenat D, Materna M, Marcot L, Vladikine N, Soret C, Vahidnezhad H, Youssefian L, Saeidian AH, Uitto J, Catherinot É, Navabi SS, Zarhrate M, Woodley DT, Jeljeli M, Abraham T, Belkaya S, Lorenzo L, Rosain J, Bayat M, Lanternier F, Lortholary O, Zakavi F, Gros P, Orth G, Abel L, Prétet JL, Fraitag S, Jouanguy E, Davis MM, Tangye SG, Notarangelo LD, Marr N, Waterboer T, Langlais D, Doorbar J, Hovnanian A, Christensen N, Bossuyt X, Shahrooei M, Casanova JL

Cell. 2021 Jun 22;:

DNA demethylation agent 5azadC downregulates HPV16 E6 expression in cervical cancer cell lines independently of TBX2 expression.

Perrard J, Morel A, Meznad K, Paget-Bailly P, Dalstein V, Guenat D, Mourareau C, Clavel C, Fauconnet S, Baguet A, Mougin C, Pretet JL

Oncol Lett. 2020 Jan;19(1):1074-1081

Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment.

Vrecko S, Guenat D, Mercier-Letondal P, Faucheu H, Dosset M, Royer B, Galaine J, Boidot R, Kim S, Jary M, Adotévi O, Borg C, Godet Y

Oncotarget. 2018 Oct 23;9(83):35394-35407

Development and interlaboratory agreement of real-time PCR for HPV16 quantification in liquid-based cervical samples.

Guenat D, Dalstein V, Mauny F, Saunier M, Briolat J, Clavel C, Riethmuller D, Mougin C, Prétet JL

Papillomavirus Res. 2018 Oct 18;:

HPV circulating tumor DNA as predictive biomarker of sustained response to chemotherapy in advanced anal carcinoma.

Bernard-Tessier A, Jeannot E, Guenat D, Michel M, Proudhon C, Vincent-Salomon A, Bièche I, Pierga JY, Buecher B, Francois E, Kim S, André T, Jary M, Vendrely V, Samalin E, El Hajbi F, Baba-Hamed N, Meurisse A, Bidard FC, Borg C

Ann. Oncol.. 2018 Oct;29 Suppl 8:viii29

Awareness of cervical cancer among women attending an HIV treatment centre: a cross-sectional study from Morocco.

Belglaiaa E, Souho T, Badaoui L, Segondy M, Prétet JL, Guenat D, Mougin C

BMJ Open. 2018 Aug 23;8(8):e020343

Prevalence and distribution of HPV genotypes and cervical-associated lesions in sexually active young French women following HPV vaccine.

Bretagne CH, Jooste V, Guenat D, Riethmuller D, Bouvier AM, Bedgedjian I, Prétet JL, Valmary-Degano S, Mougin C

J Gynecol Obstet Hum Reprod. 2018 May 25;:

A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicine.

Herfs M, Roncarati P, Koopmansch B, Peulen O, Bruyere D, Lebeau A, Hendrick E, Hubert P, Poncin A, Penny W, Piazzon N, Monnien F, Guenat D, Mougin C, Prétet JL, Vuitton L, Segers K, Lambert F, Bours V, de Leval L, Valmary-Degano S, Quick CM, Crum CP, Delvenne P

Br. J. Cancer. 2018 Apr 27;:

High prevalence of abnormal cervical smears in a hospital cohort of French women beyond the upper age limit screening program.

Luquain A, Belglaiaa E, Guenat D, Vrecko S, Riethmuller D, Valmary-Degano S, Bedgedjian I, Chouham S, Prétet JL, Mougin C

Prev Med. 2015 Dec;81:157-62

[Analysis of MGMT methylation with the therascreen(®) MGMT Pyro(®) Kit (Qiagen). A method verification].

Luquain A, Magnin S, Guenat D, Prétet JL, Viennet G, Valmary-Degano S, Mougin C

Ann. Biol. Clin. (Paris). ;73(6):665-70

Dr GUENAT David

Fiche personne

coordonnées

Territoire

Statut

affiliation

équipes/plateformes

Recherche

Publications

Prognostic role of HPV integration status and molecular profile in advanced anal carcinoma: An ancillary study to the epitopes-HPV02 trial.

Longitudinal follow-up of HPV16 sequence after cervical infection: low intra-host variation and no correlation with clinical evolution.

Repurposing the Hybrid Capture 2 (HC2) screening test for whole-genome sequencing of human papillomaviruses.

Human papillomavirus DNA and p16 expression in head and neck squamous cell carcinoma in young French patients.

Humans with inherited T cell CD28 deficiency are susceptible to skin papillomaviruses but are otherwise healthy.

DNA demethylation agent 5azadC downregulates HPV16 E6 expression in cervical cancer cell lines independently of TBX2 expression.

Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment.

Development and interlaboratory agreement of real-time PCR for HPV16 quantification in liquid-based cervical samples.

HPV circulating tumor DNA as predictive biomarker of sustained response to chemotherapy in advanced anal carcinoma.

Awareness of cervical cancer among women attending an HIV treatment centre: a cross-sectional study from Morocco.

Prevalence and distribution of HPV genotypes and cervical-associated lesions in sexually active young French women following HPV vaccine.

A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicine.

PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma.

Exosomes and Other Extracellular Vesicles in HPV Transmission and Carcinogenesis.

5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression.

DNA damage response defect in Williams-Beuren syndrome.

Somatic mutational spectrum analysis in a prospective series of 104 gastrointestinal stromal tumors.

DNA damage response defect in Williams-Beuren syndrome.

[Molecular diagnosis of human papillomaviruses (HPV): What test(s) in clinical practice?]

Validation of Novaprep(®) HQ+ liquid-based cytology medium for high-risk human papillomavirus detection by hc2.

High prevalence of abnormal cervical smears in a hospital cohort of French women beyond the upper age limit screening program.

[Analysis of MGMT methylation with the therascreen(®) MGMT Pyro(®) Kit (Qiagen). A method verification].